1X10^6 C57BL/6 mouse splenocytes were surface stained with 1.00 ug FITC Anti-Mouse CD31 (FITC-65058, Clone: 390) (red) or 1.00 ug isotype control antibody (blue). Samples were not fixed.
1X10^6 human peripheral blood granulocytes were surface stained with 5.00 ul APC Anti-Human CD11b (APC-65116, Clone:ICRF44) (red) or isotype control antibody (blue). Samples were not fixed.
100 ul human peripheral blood were surface stained with 5.00 ul APC Anti-Human CD11c (APC-65086, Clone:3.9) and then treated with red blood cell lysis buffer. Cells were not fixed.
1X10^6 human peripheral blood granulocytes were surface stained with 10.00 ul/test APC Anti-Human CD13 (APC-65186, Clone:WM15) (red) or isotype control antibody (blue). Samples were not fixed.
1X10^6 thrombin-activated human peripheral blood platelets were surface stained with 10 ul APC Anti-Human CD62P (APC-65164, Clone:AK4) (blue) or isotype control antibody (black). Samples were not fixed.
1X10^6 human peripheral blood lymphocytes were surface stained with 10 ul APC-Anti-Human CD95 (APC-65071, clone DX2) (red) or 10 ul APC-mouse IgG1 isotype control (blue). Samples were not fixed.
1X10^6 C57BL/6 mouse bone marrow cells were surface stained with 0.30 ug APC Anti-Mouse CD11b (APC-65055, Clone: M1/70) (red) or 0.30 ug isotype control antibody (blue). Samples were not fixed.
1X10^6 C57BL/6 mouse splenocytes were surface stained with 0.20 ug APC-Anti-Mouse CD16/32 (APC-65057, clone 93) (red) or 0.20 ug APC-rat IgG2a isotype control (blue). Samples were not fixed.
